ACADIA Pharmaceuticals, Inc. (ACAD)
24.30
+0.31
(+1.29%)
USD |
NASDAQ |
Feb 23, 15:33
ACADIA Pharmaceuticals Market Cap : 4.111B for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Marker Therapeutics, Inc. | 24.34M |
| Dynavax Technologies Corp. (DELISTED) | 1.820B |
| Axsome Therapeutics, Inc. | 8.807B |
| Rhythm Pharmaceuticals, Inc. | 6.396B |
| Alnylam Pharmaceuticals, Inc. | 43.57B |
Market Cap Related Metrics
| PE Ratio | 15.64 |
| PS Ratio | 3.909 |
| PEG Ratio | 0.1545 |
| Price to Book Value | 4.482 |
| Price to Free Cash Flow | 41.35 |
| Price | 24.30 |
| Earnings Yield | 6.40% |
| PEGY Ratio | 0.1545 |
| Operating PE Ratio | 43.35 |
| Normalized PE Ratio | 15.64 |